Clinical Trials
44 trialsNCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
NCT06277011 2024-02-26
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Unknown
NCT04257175 2023-11-28
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
Sheba Medical Center
Phase 2/3 Unknown
NCT04989335 2023-11-28
Bisantrene Combination for Resistant AML
Sheba Medical Center
Phase 2 Unknown
NCT06105658 2023-10-30
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Anhui Provincial Hospital
Phase 2 Unknown
NCT05510089 2023-10-10
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
NCT05950204 2023-07-18
Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.
Coordinación de Investigación en Salud, Mexico
Phase NA Unknown
NCT05429905 2023-03-09
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
KK Women's and Children's Hospital
Phase 1/2 Unknown
NCT04271215 2022-07-20
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia
Coordinación de Investigación en Salud, Mexico
Unknown
NCT05326984 2022-04-14
Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase NA Unknown
NCT05137860 2022-01-18
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD
Hospital General de Mexico
Phase 4 Unknown
NCT05133310 2022-01-04
Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia
Hospital General de Mexico
Phase 4 Unknown
NCT05130424 2021-11-23
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
Henan Cancer Hospital
Unknown
NCT05059847 2021-09-28
Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults
Hospital General de Mexico
Phase NA Unknown
NCT04862806 2021-09-17
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
Bnai Zion Medical Center
Phase NA Unknown
NCT04931992 2021-06-18
MOLAM
University Hospital, Angers
Unknown
NCT04738955 2021-02-04
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
Shandong Provincial Hospital
Phase 4 Unknown
NCT04640064 2020-11-23
Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group
Hospital General Puyo
Unknown
NCT02772198 2020-11-03
T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies
Sheba Medical Center
Phase 1/2 Unknown
NCT02381379 2020-09-14
MSIT
Ministry of Health, Malaysia
Phase 3 Unknown
NCT04240600 2020-09-03
HEMVEF
Hospital General de Mexico
Phase NA Unknown
NCT03908138 2019-11-29
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
Shandong Provincial Hospital
Phase 4 Unknown
NCT04168788 2019-11-19
MVO
University Hospital, Angers
Phase NA Unknown
NCT04158011 2019-11-08
A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells
Sheba Medical Center
Unknown
NCT03062436 2019-07-23
To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission
Command Hospital, India
Phase NA Unknown
NCT03978364 2019-06-07
A Study of Azacitidine for Patients With Int/High -Risk MDS and AML-MRC
Shandong Provincial Hospital
Phase 3 Unknown
NCT03881774 2019-03-21
Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
Henan Cancer Hospital
Phase 1 Unknown
NCT03413046 2018-01-29
The Effect of Chemotherapy on Regulatory T Cells
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital
Unknown
NCT03040401 2017-12-19
A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)
Vastra Gotaland Region
Phase 1/2 Unknown
NCT03204838 2017-07-02
IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients
Hospital General de Mexico
Unknown
NCT03022747 2017-01-16
Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol
Vastra Gotaland Region
Phase 2 Unknown
NCT02759822 2016-05-03
Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
Instituto Nacional de Cancer, Brazil
Unknown
NCT02507479 2016-04-20
Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT00163644 2016-01-08
RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT
Bayside Health
Phase NA Unknown
NCT02275663 2015-01-06
Azacytidine Plus FLAG for Relapsed or Refractory AML
King Fahad Medical City
Phase 2 Unknown
NCT00451711 2013-12-16
Intermittent Liposomal Amphotericin B Primary Prophylaxis
Bayside Health
Phase 2 Unknown
NCT01307241 2013-11-15
RFC and MTHFR SNPs & hENT1- dCK Expression as Prognostic Factors in ALL & hENT1- dCK Expression as Prognostic Factors in AML
National Institute of Cancerología
Unknown
NCT00636922 2013-02-15
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
Bayside Health
Phase 1 Unknown
NCT01339988 2011-04-21
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)
Tel-Aviv Sourasky Medical Center
Phase 4 Unknown
NCT01329471 2011-04-06
Functional Role of RUNX1 Mutations in the Etiology of Acute Myeloid Leukemia (AML)
Hillel Yaffe Medical Center
Unknown
NCT00566566 2007-12-03
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
Sheba Medical Center
Unknown
NCT00297570 2007-10-10
Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy
Sheba Medical Center
Phase 3 Unknown
NCT00402090 2006-11-22
DHPLC Determination of TPMT Polymorphisms.
National Institute of Cancerología
Unknown
NCT00188084 2005-10-28
Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
University Hospital, Angers
Unknown